Back to companies

Bausch Health Companies Inc: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Download a free sample

Bausch Health Companies Inc (Bausch Health), formerly Valeant Pharmaceuticals International Inc, manufactures, develops, and markets a range of medical devices, over-the-counter products (OTC), and pharmaceutical products. Bausch Health offers products in the areas of dermatology, gastroenterology, eye health, neurology, aesthetic devices, dentistry, and consumer health. It offers generic and branded generic products. Bausch Health has administrative, research/laboratory, marketing, distribution, and warehousing facilities worldwide. The company offers products directly or indirectly in various regions across the world including the US, Canada, Africa, Middle East, Australia, Latin America, and Europe. It also operates manufacturing facilities in the US, Brazil, Columbia, Germany, Canada, among others. Bausch Health is headquartered in Laval, Quebec, Canada.

Headquarters Canada

Address 2150 Saint-Elzear Blvd W, Laval, Quebec, H7L4A8


Telephone 1 514 7446792

No of Employees 21,600

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange BHC (TSE)

Revenue (2020) $8.0B -6.7% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX 68.7% (2020 vs 2019)

Market Cap* $9.2B

Net Profit Margin (2020) XXX 66.4% (2020 vs 2019)

* As of and is in US$

Products and Services

Products Brands
Dermatological Anti-infective:
Atopic Dermatitis Ancobon
Psoriasis, Acitinic keratosis Arestin
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2021 Stake Sale In August, the company and its affiliates completed the sale of all of their equity interests in Amoun Pharmaceutical Company to ADQ.
2021 Contracts/Agreements In August, the company's Bausch Health, Canada secured the Health Canada approval for ARAZLO to treat people with acne vulgaris.
2021 Plans/Strategy In July, the company's subsidiary, Bausch + Lomb announced its plans to invest EUR 90 million to expand manufacturing operations at its Waterford facility.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Bausch Health Companies Inc Viatris Inc Galderma SA Endo International Plc Maruho Co Ltd
Headquarters Canada United States of America Switzerland Ireland Japan
City Laval Canonsburg La Tour-de-Peilz Dublin Kita
State/Province Quebec Pennsylvania Waadt - Osaka
No. of Employees 21,600 45,000 5,000 3,397 1,537
Entity Type Public Public Private Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Sales Growth
Image for loader
Net Income Growth
Image for loader
Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Joseph C. Papa Chairman; Chief Executive Officer Executive Board 2016 65
Tage Ramakrishna Chief Medical Officer; President - R&D Senior Management 2011 -
Kelly Webber Chief Human Resources Officer; Senior Vice President Senior Management 2018 -
Louis W. Yu Chief Quality Officer Senior Management 2016 -
Scott Hirsch Chief Strategy Officer; Senior Vice President Senior Management 2016 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer